[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United Arab Emirates Nucleic Acid Testing (NAT) Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

June 2019 | 1120 pages | ID: 2389A95D9EFEN
Venture Planning Group

US$ 4,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights
  • Five-year test volume and sales forecasts
  • Feature comparison of major analyzers
  • Profiles of market players and start-up firms developing innovative technologies and products
  • Specific product and business opportunities for instrument and consumable suppliers
Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis
  • Five-year test volume and sales forecasts for major applications, including:
  • Infectious Diseases
  • Forensic Testing
  • Cancer
  • Paternity Testing/HLA Typing
  • Genetic Diseases
  • Others
  • Five-year test volume and sales projections for over 30 NAT assays.
  • Product/Technology Review
    • Comparison of leading molecular diagnostic analyzers.
    • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
      • PCR
      • bDNA
      • SDA
      • NASBA
      • TMA
      • SSSR, and others
      • LCR
    • Companies, universities and research centers developing new molecular- diagnostic technologies and products.
    Competitive Assessments

    Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

    Opportunities and Strategic Recommendations
    • New product development opportunities with potentially significant market appeal during the next five years.
    • Alternative market penetration strategies.
    • Potential market entry barriers and risks.
    • Business planning issues and concerns.
    Contains 1,120 pages and 48 tables
    I. INTRODUCTION

    II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Instrumentation
    B. Reagent Kits and Test Systems/panels
    C. Computers, Software and Automation
    D. Auxiliary Products

    III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

    V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    VI. MOLECULAR DIAGNOSTIC TECHNOLOGY REVIEW

    A. DNA Sequencing
    B. DNA and RNA Probe Technologies
    C. Detection Technologies
    D. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    E. Pharmacogenomics
    F. Competing/complementing
      1. Monoclonal Antibodies/Immunoassays
      2. RNA Probes
      3. Two-Dimensional Electrophoresis
      4. Flow Cytometry

    VII. MOLECULAR DIAGNOSTIC INSTRUMENTATION REVIEW

    VIII. MAJOR APPLICATIONS

      1. Microbiology/Infectious Diseases
        a. Overview
        b. Major Infectious Diseases
          AIDS/HIV
          Adenovirus
          Aeromonads
          Anthrax/Bacillus Anthracis
          Arboviruses
          Babesiosis
          Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
          Blastocystis Hominis
          Brucella
          Campylobacter
          Candida
          Chagas Disease
          Chancroid
          Chlamydia
          Clostridium Difficile
          Coronaviruses
          Coxsackieviruses
          Creutzfeldt-Jakob’s Disease
          Cryptosporidium Parvum
          Cyclospora Cayetanensis
          Cytomegalovirus
          Ebola Virus
          E. Coli
          Echovirus
          Encephalitis
          Enteroviruses
          Epstein-Barr Virus
          Giardia Lamblia
          Gonorrhea
          Granuloma Inguinale
          Hantavirus
          Helicobacter Pylori
          Hepatitis
          Herpes Simplex Virus
          Human Herpes Virus-6 (HHV-6)
          Influenza Viruses
          Legionella
          Lyme Disease
          Lymphogranuloma Venereum (LGV)
          Malaria
          Measles (Rubeola)
          Meningitis
          Microsporidium
          Mononucleosis
          Mumps
          Mycoplasma
          Papillomaviruses
          Parvovirus B19
          Pneumonia
          Polyomaviruses
          Pseudomonas Aeruginosa
          Rabies
          Respiratory Syncytial Virus (RSV)
          Rhinoviruses
          Rotavirus
          Rubella
          Salmonellosis
          Septicemia
          Shigellosis
          Staphylococcus Aureus
          Streptococci
          Syphilis
          Toxoplasmosis
          Trichomonas Vaginalis
          Tuberculosis
          Vibrio
          West Nile Virus
          Yersinia
      2. Cancer Testing
        a. Overview
        b. Major Cancer Types
          Prostate
          Lung
          Colon and Rectum
          Breast
          Skin
          Uterine
          Leukemia
          Oral
        c. Oncogenes
          Abl/abl-bcr
          AIB1
          BCL-2
          BRCA1
          CD44
          C-fos
          C-myb
          C-myc
          CYP17
          Erb-B
          HPC1
          N-myc
          P40
          P51
          P53
          PIK3CA
          PTI-1
          Ras
          Reg
          Sis
          Src
      3. Genetic Diseases
        a. Overview
        b. Nucleic Acid Amplification
        c. Chromosome Imaging
        d. Genomics Technologies
        e. Proteomics Technologies
        f. Current Pharmacogenomic Tests
        g. Future Pharmacogenomic Testing
        h. Major Diseases
          Achondroplasia
          Autosomal Dominant Polycystic Kidney Disease
          Cancer
          Cosmetogenomics
          Cystic Fibrosis
          Down's Syndrome
          Duchenne and Becker Muscular Dystrophy
          Factor V (Leiden)
          Factor IX Deficiency
          Fragile X Syndrome
          Heart Disease
          Hemochomatosis
          Hemophilia
          Huntington's Disease
          Maternal-Fetal Incompatibility
          Multiple Endocrine Neoplasia
          Phenylketonuria (PKU)
          Polycystic Kidney Disease (PKD)
          Prenatal Screening
          Retinitis Pigmentosa
          Retinoblastoma
          Sickle Cell Anemia
          Spinal Muscular Atrophy
          Vitamin B12 Metabolism
        i. Social Issues and Concerns
      4. Forensic Testing
        a. Overview
        b. Multilocus and Single Locus Probes
          Multilocus Probes
          Single Locus Probes
          PCR and RFLP
        c. DNA Profile Data Banks
        d. Judicial Implementation
        e. Major Crime Categories
        f. Factors Contributing to the DNA Probe Market Expansion
          Technology Availability
          Use of Hair as Evidence
        g. Wildlife Forensics
      5. Paternity Testing/HLA Typing
      6. Other Applications
        a. Disease Susceptibility Testing
        b. Cardiovascular Diseases
        c. Diabetes
        d. Alzheimer's Disease
        e. Periodontal Disease
        f. Plasma Purification
        g. Organ Transplantation
        h. Water Contamination
        i. Other

    IX. MARKET SIZE AND GROWTH: TEST VOLUME AND SALES FORECASTS

    X. COMPETITIVE ASSESSMENTS

    Abbott
    Agilent Technologies
    Applied Gene Technologies
    Arca Biopharma
    Beckman Coulter/Danaher
    Becton Dickinson
    Biokit
    bioMerieux
    Bio-Rad
    Biotest
    CellMark Forensics/LabCorp
    Cepheid
    Decode Genetics
    Diadexus
    Eiken
    Elitech Group
    Enzo
    Exact Sciences
    Fujirebio
    Grifols
    Hologic/Gen-Probe
    Illumina
    Kreatech/Leica
    Li-Cor Biosciences
    Monogram Biosciences/LabCorp
    Myriad Genetics
    Ortho-Clinical Diagnostics
    Perkin Elmer/Caliper
    Proteome Sciences
    Qiagen
    Roche
    Scienion
    Sequenom
    Shimadzu
    Siemens
    Sierra Molecular
    Takara Bio
    Tecan Group
    Thermo Fisher/Affymetrix

    XI. APPENDIX: RESEARCH CENTERS DEVELOPING NEW TECHNOLOGIES AND PRODUCTS

    LIST OF TABLES

    Molecular Diagnostics Test Volume and Sales Forecasts by Major Application
    Molecular Diagnostics Test Volume by Major Application
    Major Infectious Disease Test Volume by Assay
    Major Infectious Disease Test Volume by Method
    Molecular Diagnostics Market by Major Application
    Major Infectious Disease Diagnostics Market by Assay
    Major Companies Developing or Marketing Salmonella Molecular Diagnostic Tests
    Major Companies Developing or Marketing AIDS Molecular Diagnostic Tests
    Major Companies Developing or Marketing Adenovirus Molecular Diagnostic Tests
    Major Companies Developing or Marketing Bartonella Molecular Diagnostic Tests
    Major Companies Developing or Marketing Campylobacter Molecular Diagnostic Tests
    Major Companies Developing or Marketing Candida Molecular Diagnostic Tests
    Major Companies Developing or Marketing Chlamydia Molecular Diagnostic Tests
    Major Companies Developing or Marketing Clostridium Molecular Diagnostic Tests
    Major Companies Developing or Marketing Coronavirus Molecular Diagnostic Tests
    Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic Tests
    Major Companies Developing or Marketing CMV Molecular Diagnostic Tests
    Major Companies Developing or Marketing Echovirus Molecular Diagnostic tests
    Major Companies Developing or Marketing Enterovirus Molecular Diagnostic tests
    Major Companies Developing or Marketing EBV Molecular Diagnostic Tests
    Major Companies Developing or Marketing Giardia Molecular Diagnostic Tests
    Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic Tests
    Major Companies Developing or Marketing Hantavirus Molecular Diagnostic Tests
    Major Companies Developing or Marketing Helicobacter Molecular Diagnostic Tests
    Major Companies Developing or Marketing Hepatitis Molecular Diagnostic Tests
    Major Companies Developing or Marketing Herpes Molecular Diagnostic Tests
    Major Companies Developing or Marketing Influenza Molecular Diagnostic Tests
    Major Companies Developing or Marketing Legionella Molecular Diagnostic Tests
    Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic Tests
    Major Companies Developing or Marketing Measles Molecular Diagnostic Tests
    Major Companies Developing or Marketing Meningitis Molecular Diagnostic Tests
    Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic Tests
    Major Companies Developing or Marketing Mumps Molecular Diagnostic Tests
    Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic Tests
    Major Companies Developing or Marketing Pneumonia Molecular Diagnostic Tests
    Major Companies Developing or Marketing RSV Molecular Diagnostic Tests
    Major Companies Developing or Marketing Rotavirus Molecular Diagnostic Tests
    Major Companies Developing or Marketing Rubella Molecular Diagnostic Tests
    Major Companies Developing or Marketing Septicemia Molecular Diagnostic Tests
    Major Companies Developing or Marketing Shigella Molecular Diagnostic Tests
    Major Companies Developing or Marketing Streptococci Molecular Diagnostic Tests
    Major Companies Developing or Marketing Syphilis Molecular Diagnostic Tests
    Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic Tests
    Major Companies Developing or Marketing Trichomonas Molecular Diagnostic Tests
    Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic Tests
    Oncogenes Potential Application in Cancer Diagnosis
    Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
    Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases


    More Publications